Cramer highlights Goldman, Wells Fargo and Johnson & Johnson as buys amid market weakness

Cramer highlights Goldman, Wells Fargo and Johnson & Johnson as buys amid market weakness
Cramer names top buys

Investor sentiment remains fragile as bank earnings and pressure on memory stocks weigh on Tuesday trading. Against that backdrop, Jim Cramer argues that selected shares still offer buying opportunities, pointing to financials and healthcare names with earnings support and balance-sheet strength.

Highlights

  • Goldman Sachs remains Cramer's top bank pick after an earnings beat, demonstrating profit generation beyond IPO and M&A activity.
  • Wells Fargo stays on Cramer's buy list despite dropping over 1% post-mixed quarter, supported by a long-term investment thesis.
  • Johnson & Johnson's nearly 5.5% decline post-earnings is seen as an entry point, with revenue up approximately 6% and exceeding estimates.

Buy calls from Tuesday's market sell-off

As reported by CNBC Investing Club, stocks fall Tuesday as investors assess a wave of major bank earnings and continued weakness in memory stocks, including Micron. Cramer says investors are becoming overly negative about the broader market and argues that some stocks are still moving higher or have room to rise despite the cautious mood.

He says Goldman Sachs remains his preferred bank stock after the lender posts an earnings beat, adding that its business mix shows it can generate substantial profits beyond IPO and M&A activity. Wells Fargo, which declines more than 1% after a mixed quarter, also stays on his buy list because he says the investment case rests on a longer-term view.

Cramer also says Johnson & Johnson's roughly 5.5% drop after quarterly results creates an entry point rather than a warning sign. He notes that revenue rises about 6% and beats Wall Street estimates, and he backs the stock for its dividend and AAA balance sheet.

Market context and club disclosures

The recommendations come as Cramer pushes back on growing pessimism in the market, even after prominent investor Paul Tudor Jones warns on CNBC that 2027 could be a difficult year for stocks. Cramer says he prefers to focus on actual trading patterns and individual opportunities instead of assuming the whole market must move lower.

Earlier in the session, the club buys more Kimberly-Clark, while other stocks discussed in the rapid-fire segment include JPMorgan Chase, Citi, UnitedHealth and Domino's Pizza. CNBC Investing Club also reminds subscribers that trade alerts are sent before any transaction in Jim Cramer's Charitable Trust, with a 45-minute waiting period before trust trades and a 72-hour wait if a stock has been discussed on CNBC television.

Our earlier coverage of the U.S. semiconductor sell-off highlighted how memory-chip names led declines as investors digested rising competitive risks—particularly signs of technological progress from China’s CXMT—and growing caution around AI-related spending. We noted that the pullback also reflected profit-taking after a strong year for the sector, with warnings from industry executives adding to the risk-off tone across major chipmakers.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.